Purchase Order 75N91024P00499
Award Date 6/16/24
Potential Completion Date 6/16/25
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...
- This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for $21,588.00 in equipment. The contract has no set-aside designation. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...
- This federal contract award was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The $16,500 firm-fixed-price purchase order is for the delivery of Oxford Nanopore's next-generation genomic sequencing equipment, consumables, reagents, software licenses, and associated services. The contract does not have a set-aside designation. Oxford Nanopore Technologies Inc....
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $12,500.00 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a 12-month software license and device warranty on a GridION system. The award period runs from August 9, 2021, to August 8, 2022, and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of nanopore-based...
- This $6,678 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company that develops and provides nanopore-based electronic DNA/RNA sequencing systems. The award does not have a set-aside designation. Through this contract, Oxford Nanopore is providing its next-generation sequencing equipment, consumables, and...
- This federal contract award, valued at $13,500.00, was issued by the National Cancer Institute (NCI) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of GridION and PromethION2 SOLO devices from December 1, 2024, to November 30, 2025. The contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of innovative nanopore-based electronic systems for analyzing single...
- This federal contract award, valued at $30,340.00, was issued by the National Cancer Institute (NCI), a civilian agency within the U.S. government, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the initial supply of flow cells to be used with Oxford Nanopore's P2 instrument for long-read DNA sequencing. The contract has a firm fixed-price structure and an ultimate completion date of September 10, 2025. In addition to this specific...
- This $12,500.00 firm fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract provides a GridION license and warranty for the NHLBI's DNA Sequencing and Genomics Core Facility, with a period of performance from March 17, 2025, to March 16, 2026. Oxford Nanopore Technologies Inc. is a prime...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for $15,000.00 and does not have a set-aside designation. It provides for the delivery of Oxford Nanopore's GridION Standard Support, which includes their nanopore-based electronic systems for analyzing single molecules such as DNA, RNA, and proteins. This contract supports...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, provides a software license and device warranty for two GridION instruments to support the Food and Drug Administration's (FDA) next-generation sequencing efforts. The $25,000.00 firm-fixed-price purchase order has a period of performance through September 27, 2025. Oxford Nanopore Technologies is a provider of innovative nanopore-based sequencing platforms, which have been...